연구동향 분석

중증근무력증의 임상 분류와 척도

김승우 신하영 2021년

논문상세정보
인용/피인용
' 중증근무력증의 임상 분류와 척도' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • classification
  • myasthenia gravis
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
909 0

0.0%

' 중증근무력증의 임상 분류와 척도' 의 참고문헌

  • “Maximal” thymectomy for myasthenia gravis. Results
  • Thymectomy as primary therapy in myasthenia gravis
    Olanow CW [1987]
  • The MG composite: a valid and reliable outcome measure for myasthenia gravis
    Burns TM [2010]
  • Studies in myasthenia gravis; review of two hundred eighty-two cases at the Mount Sinai Hospital, New York City
    Osserman KE [1958]
  • Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients
    Osserman KE [1971]
  • Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
  • Reliability testing of the quantitative myasthenia gravis score
    Barohn RJ [1998]
  • Recommendations for myasthenia gravis clinical trials
    Benatar M [2012]
  • Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis
    Wolfe GI [2002]
  • Randomized trial of thymectomy in myasthenia gravis
    Wolfe GI [2016]
  • Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis
    Tindall RS [1987]
  • Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis
    Qureshi AI [1999]
  • Physicianand self-assessed myasthenia gravis activities of daily living score
    Lee HL [2018]
  • Observations of the natural history of myasthenia gravis and the effect of thymectomy
  • New classification system for myasthenia gravis
    Barohn R [1994]
  • Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability
  • Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America
  • Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity
    Besinger UA [1983]
  • Myasthenia gravis activities of daily living profile
    Wolfe GI [1999]
  • Myasthenia gravis
    Gilhus NE [2016]
  • MG-ADL: still a relevant outcome measure
    Muppidi S [2011]
  • Low-dose tacrolimus treatment in thymectomised and steroid-dependent myasthenia gravis
    Kawaguchi N [2004]
  • Long‐term correlation of clinical course and acetylcholine receptor antibody in patients with myasthenia gravis
    Besinger U [1981]
  • Long-term effects of plasma exchange in myasthenia. Results of a randomized study
    Gajdos P [1983]
  • Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis
    김율희 [2019]
  • Etanercept treatment in corticosteroid-dependent myasthenia gravis
    Rowin J [2004]
  • Efficacy of low-dose FK506 in the treatment of Myasthenia gravis--a randomized pilot study
    Nagane Y [2005]
  • Development of the MG-DIS: an ICF-based disability assessment instrument for myasthenia gravis
    Raggi A [2014]
  • Development of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapy
    Wolfe GI [2003]
  • Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite
    Burns TM [2008]
  • Benefits of FK506 (tacrolimus) for residual, cyclosporin- and prednisone-resistant myasthenia gravis: one-year follow-up of an open-label study
    Ponseti JM [2005]
  • Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis
    Takamori M [2004]
  • A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score
    Sanders DB [2003]
  • A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis
    Pasnoor M [2016]
  • A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. Myasthenia Gravis Clinical Study Group
    [1993]
  • A clinical therapeutic trial of cyclosporine in myasthenia gravis
    Tindall RS [1993]